These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 19191294

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E, Langfort R, Roszkowski-Sliz K.
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [Abstract] [Full Text] [Related]

  • 4. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY, Li GD, Liu WP, Xie B, Jiang YH.
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH, Kim GE, Choi YD, Lee JS, Lee JH, Nam JH, Choi C.
    Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY, Li GD, Liu HB, Jiang LL.
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [Abstract] [Full Text] [Related]

  • 10. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
    Wu GP, Zhang SS, Fang CQ, Liu SL, Wang EH.
    Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
    [Abstract] [Full Text] [Related]

  • 11. HBME-1 immunostaining in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid.
    Rahmani A, Dehghani MZ, Afshar NM, Heidarian H, Tahririan R.
    Indian J Pathol Microbiol; 2011 Aug; 54(3):460-3. PubMed ID: 21934203
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV, Nesland JM, Davidson B.
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [Abstract] [Full Text] [Related]

  • 16. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion.
    Ueda J, Iwata T, Ono M, Takahashi M.
    Diagn Cytopathol; 2006 Jan; 34(1):6-10. PubMed ID: 16355377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations.
    Wieczorek TJ, Krane JF.
    Cancer; 2000 Oct 25; 90(5):312-9. PubMed ID: 11038429
    [Abstract] [Full Text] [Related]

  • 19. [Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies].
    Chenard-Neu MP, Kabou A, Mechine A, Brolly F, Orion B, Bellocq JP.
    Ann Pathol; 1998 Dec 25; 18(6):460-5. PubMed ID: 10051912
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.